Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

67.22 -2.41 (-3.46%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Why Exact Sciences Stock Blasted Higher on Tuesday
An impressive beat-and-raise third quarter made the company a standout that day. 
Via The Motley Fool
Palantir Weighs On Wall Street, Bitcoin Slumps 5%: What's Moving Markets Tuesday?
Risk appetite cooled on Tuesday as investors interpreted the latest batch of corporate earnings as solid but not spectacular, offering a convenient excuse to take profits after strong year-to-date... 
Via Benzinga
Earnings Scheduled For November 3, 2025
 
Via Benzinga
Earnings Preview: Exact Sciences
 
Via Benzinga
These Analysts Raise Their Forecasts On Exact Sciences Following Better-Than-Expected Q3 Results
 
Via Benzinga
Amazon To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday
 
Via Benzinga
EXAS Q3 Deep Dive: Cologuard Plus, Care Gap Programs, and New Test Launches Drive Growth
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 20% year on year to $850.7 million. The company’s full-year... 
Via StockStory
Exact Sciences to Participate in November Investor Conference
From Exact Sciences Corp.
Via Business Wire
Exact Sciences (EXAS) Q3 2025 Earnings Transcript
Exact Sciences (EXAS) Q3 2025 Earnings Transcript 
Via The Motley Fool
Topics Earnings
Exact Sciences (NASDAQ:EXAS) Reports Upbeat Q3, Stock Soars
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 20% year on year to $850.7 million. The company’s full-year... 
Via StockStory
Exact Sciences Flirts With A Breakout On Guidance Hike, Sales Beat
Exact Sciences stock jumped late Monday on strong third-quarter sales, despite continued losses. The company raised its sales guide. 
Via Investor's Business Daily
Topics Earnings
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Exact Sciences Announces Third Quarter 2025 Results
From Exact Sciences Corp.
Via Business Wire
Nvidia, Amazon Extend Rally, Bitcoin Sinks To $107,000: What's Moving Markets Monday?
Wall Street opened the week on a mixed note on Monday. 
Via Benzinga
Should You Buy Exact Sciences Stock Before Nov. 3?
The company's outlook is improving as its innovative ways continue to pay off. 
Via The Motley Fool
Exact Sciences (EXAS) Reports Q3: Everything You Need To Know Ahead Of Earnings
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) will be announcing earnings results this Monday after market hours. Here’s what to expect. 
Via StockStory
3 Unprofitable Stocks with Questionable Fundamentals
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth. 
Via StockStory
3 Cash-Producing Stocks We Think Twice About
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
Exact Sciences Presents New Findings at ACG 2025 Demonstrating How the Cologuard Test Helps Improve Adherence and Close Screening Gaps
From Exact Sciences Corp.
Via Business Wire
11 Analysts Have This To Say About Exact Sciences
 
Via Benzinga
Immuno-Oncology Stocks Q2 Recap: Benchmarking Exact Sciences (NASDAQ:EXAS)
Looking back on immuno-oncology stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Exact Sciences (NASDAQ:EXAS) and its peers. 
Via StockStory
Topics Artificial Intelligence
3 High-Flying Stocks We Steer Clear Of
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated... 
Via StockStory
Topics Firearms
Exact Sciences Schedules Third Quarter 2025 Earnings Call
From Exact Sciences Corp.
Via Business Wire
New Study in Journal of the National Cancer Institute Finds Cologuard Plus™ Provides the Most Life-Years Gained with the Fewest Colonoscopies
From Exact Sciences Corp.
Via Business Wire
What Analysts Are Saying About Exact Sciences Stock
 
Via Benzinga
Decoding Life's Blueprint: New Tech Maps RNA-Protein Interactions, Unlocking Disease Cures
A monumental leap in biomedical research has been announced with the development of a breakthrough technology capable of mapping the entire intricate network of RNA-protein interactions within human... 
Via MarketMinute
Topics Artificial Intelligence Derivatives
Exact Sciences (EXAS) Stock Trades Up, Here Is Why
Shares of diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) jumped 2.2% in the afternoon session after the Nancy Gardner Sewell MCED Act advanced in the U.S. House, a development that could... 
Via StockStory
Horror Icon Matthew Lillard and Exact Sciences Help Adults 45+ Conquer Fear and Get Screened for Colon Cancer with the Cologuard® Test
From Exact Sciences Corp.
Via Business Wire
Peering Into Exact Sciences's Recent Short Interest
 
Via Benzinga
Demystifying Exact Sciences: Insights From 9 Analyst Reviews
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.